Publication
Jul 2011
A number of changes have taken place in the global pharmaceutical marketplace over the last decade that are putting pressure on the large research and development (R&D)-based pharmaceutical transnational corporations (TNCs) to change the way they do business. This policy brief examines how some of these changes interface with intellectual property (IP) policies, and suggests what that may mean for IP issues and pharmaceuticals in the years ahead.
Download |
English (PDF, 8 pages, 483 KB) |
---|---|
Author | Brian Tempest |
Series | ICTSD Publications |
Issue | 10 |
Publisher | International Centre for Trade and Sustainable Development (ICTSD) |
Copyright | © 2011 International Centre for Trade and Sustainable Development (ICTSD), United Nations Conference on Trade and Development (UNCTAD). The work is licensed under the Creative Commons Attribution-Non-commercial-No Derivative Works 3.0 Licence. |